Startup SpotitEarly is pioneering an innovative early cancer screening test based on breath samples and powered by artificial intelligence and the strong scent detection of trained dogs. SpotitEarly ...
8don MSN
Seeing thyroid cancer in a new light: When AI meets label-free imaging in the operating room
Thyroid cancer is the most common endocrine cancer, affecting more people each year as detection rates continue to rise.
A blood-based colorectal cancer (CRC) screening test, SimpleScreen™, has shown a significant leap in performance, ...
Helio Genomics announced a partnership with Ohio-based LiverRight Inc. to integrate its new early liver cancer detection test ...
Proposed collaboration aims to integrate cutting-edge AI and genomic insights to advance guideline-directed medical therapy SAN FRANCISCO--(BUSINESS WIRE)-- Viz.ai, the leader in AI-powered disease ...
Thyroid cancer is the most common endocrine cancer, affecting more people each year as detection rates continue to rise.
We combine affordable thermal cameras with advanced AI to analyse temperature maps of the human body without radiation, ...
Colorectal cancer (CRC) is the second-leading cause of cancer-related deaths in Europe and the U.S.—yet when detected early, the 5-year survival rate jumps to 91%. While colonoscopy remains the gold ...
Galleri is a blood test that aims to detect over 50 types of cancer early. It analyzes cell-free DNA (cfDNA) and methylation patterns to identify potential cancer signals. The test is intended for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback